Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease
Kenichi Horinouchi(Icahn School of Medicine at Mount Sinai), Edward H. Schuchman(Icahn School of Medicine at Mount Sinai), Shai Erlich(Icahn School of Medicine at Mount Sinai), Daniel P. Perl(Center for Neuroscience and Regenerative Medicine), Colin L. Stewart(Agency for Science, Technology and Research), Robert J. Desnick(Icahn School of Medicine at Mount Sinai), Konrad Sandhoff(University of Bonn), Charles L. Bisgaier, Klaus Ferlinz(University of Bonn)
Cited by 477
Related Papers
Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium
|Nature Medicine|2008|833
Acid Sphingomyelinase–Deficient Human Lymphoblasts and Mice Are Defective in Radiation-Induced Apoptosis
|Cell|1996|797
TDP-43 Proteinopathy and Motor Neuron Disease in Chronic Traumatic Encephalopathy
|Journal of Neuropathology & Experimental Neurology|2010|653
Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine -1-phosphate therapy
|Nature Medicine|2000|596
Acid sphingomyelinase activity triggers microparticle release from glial cells
|The EMBO Journal|2009|586